[{"Assets_0_Q3_USD":640222000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-123586000.0,"NetIncomeLoss_1_Q3_USD":-27307000.0,"NetIncomeLoss_3_Q3_USD":-99741000.0,"StockholdersEquity_0_Q3_USD":419089000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]